Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity

Lucio Tentori, Alessia Muzi, Annalisa Susanna Dorio, Stefano Bultrini, Emanuela Mazzon, Pedro M. Lacal, Girish M. Shah, Jie Zhang, Pierluigi Navarra, Giuseppe Nocentini, Salvatore Cuzzocrea, Grazia Graziani

Research output: Contribution to journalArticle

Abstract

Poly(ADP-ribose) polymerase (PARP)-1, which plays a key role in DNA repair, inflammation and transcription, has recently been shown to be involved in angiogenesis. The aim of this study was to investigate PARP-1 role in melanoma aggressiveness and chemoresistance in vivo using clones stably silenced for PARP-1 expression. Whilst the growth characteristics of PARP-1-deficient melanoma cells were comparable to those of PARP-1-proficient cells in vitro, their tumourigenic potential in vivo was significantly compromised. In fact, mice challenged intra-muscle with PARP-1-deficient cells showed a delayed development of measurable tumour nodules, which were also significantly reduced in size with respect to those of mice inoculated with PARP-1-proficient cells. Moreover, animals challenged intra-cranially with PARP-1-deficient cells, a model that mimics CNS localisation of melanoma, showed an increased survival. Immunohistochemical analyses of PARP-1-depleted melanoma grafts indicated a reduced expression of the angiogenesis marker PECAM-1/CD31 and of the pro-inflammatory mediators TNF-α and GITR. Notably, PARP-1-silenced melanoma was extremely sensitive to temozolomide, an anticancer agent used for the treatment of metastatic melanoma. These results provide novel evidence for a direct role of PARP-1 in tumour aggressiveness and chemoresistance.

Original languageEnglish (US)
Pages (from-to)1302-1314
Number of pages13
JournalEuropean Journal of Cancer
Volume44
Issue number9
DOIs
StatePublished - Jun 2008
Externally publishedYes

Fingerprint

Melanoma
Growth
temozolomide
Poly (ADP-Ribose) Polymerase-1
CD31 Antigens
DNA Repair
Antineoplastic Agents
Neoplasms
Clone Cells
Inflammation
Transplants
Muscles

Keywords

  • Angiogenesis
  • Melanoma
  • Poly(ADP-ribose) polymerase
  • Temozolomide

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

Tentori, L., Muzi, A., Dorio, A. S., Bultrini, S., Mazzon, E., Lacal, P. M., ... Graziani, G. (2008). Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity. European Journal of Cancer, 44(9), 1302-1314. https://doi.org/10.1016/j.ejca.2008.03.019

Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity. / Tentori, Lucio; Muzi, Alessia; Dorio, Annalisa Susanna; Bultrini, Stefano; Mazzon, Emanuela; Lacal, Pedro M.; Shah, Girish M.; Zhang, Jie; Navarra, Pierluigi; Nocentini, Giuseppe; Cuzzocrea, Salvatore; Graziani, Grazia.

In: European Journal of Cancer, Vol. 44, No. 9, 06.2008, p. 1302-1314.

Research output: Contribution to journalArticle

Tentori, L, Muzi, A, Dorio, AS, Bultrini, S, Mazzon, E, Lacal, PM, Shah, GM, Zhang, J, Navarra, P, Nocentini, G, Cuzzocrea, S & Graziani, G 2008, 'Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity', European Journal of Cancer, vol. 44, no. 9, pp. 1302-1314. https://doi.org/10.1016/j.ejca.2008.03.019
Tentori, Lucio ; Muzi, Alessia ; Dorio, Annalisa Susanna ; Bultrini, Stefano ; Mazzon, Emanuela ; Lacal, Pedro M. ; Shah, Girish M. ; Zhang, Jie ; Navarra, Pierluigi ; Nocentini, Giuseppe ; Cuzzocrea, Salvatore ; Graziani, Grazia. / Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity. In: European Journal of Cancer. 2008 ; Vol. 44, No. 9. pp. 1302-1314.
@article{8e8cb75e5f82469fa8106d726e226cbf,
title = "Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity",
abstract = "Poly(ADP-ribose) polymerase (PARP)-1, which plays a key role in DNA repair, inflammation and transcription, has recently been shown to be involved in angiogenesis. The aim of this study was to investigate PARP-1 role in melanoma aggressiveness and chemoresistance in vivo using clones stably silenced for PARP-1 expression. Whilst the growth characteristics of PARP-1-deficient melanoma cells were comparable to those of PARP-1-proficient cells in vitro, their tumourigenic potential in vivo was significantly compromised. In fact, mice challenged intra-muscle with PARP-1-deficient cells showed a delayed development of measurable tumour nodules, which were also significantly reduced in size with respect to those of mice inoculated with PARP-1-proficient cells. Moreover, animals challenged intra-cranially with PARP-1-deficient cells, a model that mimics CNS localisation of melanoma, showed an increased survival. Immunohistochemical analyses of PARP-1-depleted melanoma grafts indicated a reduced expression of the angiogenesis marker PECAM-1/CD31 and of the pro-inflammatory mediators TNF-α and GITR. Notably, PARP-1-silenced melanoma was extremely sensitive to temozolomide, an anticancer agent used for the treatment of metastatic melanoma. These results provide novel evidence for a direct role of PARP-1 in tumour aggressiveness and chemoresistance.",
keywords = "Angiogenesis, Melanoma, Poly(ADP-ribose) polymerase, Temozolomide",
author = "Lucio Tentori and Alessia Muzi and Dorio, {Annalisa Susanna} and Stefano Bultrini and Emanuela Mazzon and Lacal, {Pedro M.} and Shah, {Girish M.} and Jie Zhang and Pierluigi Navarra and Giuseppe Nocentini and Salvatore Cuzzocrea and Grazia Graziani",
year = "2008",
month = "6",
doi = "10.1016/j.ejca.2008.03.019",
language = "English (US)",
volume = "44",
pages = "1302--1314",
journal = "European Journal of Cancer",
issn = "0959-8049",
publisher = "Elsevier Limited",
number = "9",

}

TY - JOUR

T1 - Stable depletion of poly (ADP-ribose) polymerase-1 reduces in vivo melanoma growth and increases chemosensitivity

AU - Tentori, Lucio

AU - Muzi, Alessia

AU - Dorio, Annalisa Susanna

AU - Bultrini, Stefano

AU - Mazzon, Emanuela

AU - Lacal, Pedro M.

AU - Shah, Girish M.

AU - Zhang, Jie

AU - Navarra, Pierluigi

AU - Nocentini, Giuseppe

AU - Cuzzocrea, Salvatore

AU - Graziani, Grazia

PY - 2008/6

Y1 - 2008/6

N2 - Poly(ADP-ribose) polymerase (PARP)-1, which plays a key role in DNA repair, inflammation and transcription, has recently been shown to be involved in angiogenesis. The aim of this study was to investigate PARP-1 role in melanoma aggressiveness and chemoresistance in vivo using clones stably silenced for PARP-1 expression. Whilst the growth characteristics of PARP-1-deficient melanoma cells were comparable to those of PARP-1-proficient cells in vitro, their tumourigenic potential in vivo was significantly compromised. In fact, mice challenged intra-muscle with PARP-1-deficient cells showed a delayed development of measurable tumour nodules, which were also significantly reduced in size with respect to those of mice inoculated with PARP-1-proficient cells. Moreover, animals challenged intra-cranially with PARP-1-deficient cells, a model that mimics CNS localisation of melanoma, showed an increased survival. Immunohistochemical analyses of PARP-1-depleted melanoma grafts indicated a reduced expression of the angiogenesis marker PECAM-1/CD31 and of the pro-inflammatory mediators TNF-α and GITR. Notably, PARP-1-silenced melanoma was extremely sensitive to temozolomide, an anticancer agent used for the treatment of metastatic melanoma. These results provide novel evidence for a direct role of PARP-1 in tumour aggressiveness and chemoresistance.

AB - Poly(ADP-ribose) polymerase (PARP)-1, which plays a key role in DNA repair, inflammation and transcription, has recently been shown to be involved in angiogenesis. The aim of this study was to investigate PARP-1 role in melanoma aggressiveness and chemoresistance in vivo using clones stably silenced for PARP-1 expression. Whilst the growth characteristics of PARP-1-deficient melanoma cells were comparable to those of PARP-1-proficient cells in vitro, their tumourigenic potential in vivo was significantly compromised. In fact, mice challenged intra-muscle with PARP-1-deficient cells showed a delayed development of measurable tumour nodules, which were also significantly reduced in size with respect to those of mice inoculated with PARP-1-proficient cells. Moreover, animals challenged intra-cranially with PARP-1-deficient cells, a model that mimics CNS localisation of melanoma, showed an increased survival. Immunohistochemical analyses of PARP-1-depleted melanoma grafts indicated a reduced expression of the angiogenesis marker PECAM-1/CD31 and of the pro-inflammatory mediators TNF-α and GITR. Notably, PARP-1-silenced melanoma was extremely sensitive to temozolomide, an anticancer agent used for the treatment of metastatic melanoma. These results provide novel evidence for a direct role of PARP-1 in tumour aggressiveness and chemoresistance.

KW - Angiogenesis

KW - Melanoma

KW - Poly(ADP-ribose) polymerase

KW - Temozolomide

UR - http://www.scopus.com/inward/record.url?scp=44449115048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44449115048&partnerID=8YFLogxK

U2 - 10.1016/j.ejca.2008.03.019

DO - 10.1016/j.ejca.2008.03.019

M3 - Article

C2 - 18440222

AN - SCOPUS:44449115048

VL - 44

SP - 1302

EP - 1314

JO - European Journal of Cancer

JF - European Journal of Cancer

SN - 0959-8049

IS - 9

ER -